Actively Recruiting
Study of Pancreatic Adenocarcinoma Using Clinical Data and Biological Samples to Support Future Research
Led by University Hospital, Toulouse · Updated on 2026-03-19
1500
Participants Needed
8
Research Sites
4 weeks
Total Duration
AI-Summary
What this Trial Is About
Pancreatic cancer is a leading cause of cancer death in Western countries, with over 90% of cases caused by adenocarcinoma. Surgical removal of the tumor is currently the only curative treatment but is possible in only 10 to 15% of cases. This research aims to enhance understanding and treatment of pancreatic adenocarcinoma by enriching an existing biobank with fresh tumor tissue and genetic analysis to support future studies on diagnostic tools, tumor development, therapeutic targets, and chemotherapy response.
CONDITIONS
Brief Title
Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Research Team
B
Barbara BOURNET, MD, PhD
C
Cindy CANIVET, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
